0001209191-21-046494.txt : 20210713
0001209191-21-046494.hdr.sgml : 20210713
20210713162239
ACCESSION NUMBER: 0001209191-21-046494
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210710
FILED AS OF DATE: 20210713
DATE AS OF CHANGE: 20210713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McNeill Jonathan
CENTRAL INDEX KEY: 0001824673
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 211088097
MAIL ADDRESS:
STREET 1: C/O DYNE THERAPEUTICS, INC.
STREET 2: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-10
0
0001818794
Dyne Therapeutics, Inc.
DYN
0001824673
McNeill Jonathan
C/O DYNE THERAPEUTICS, INC.
830 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
See Remarks
Stock Option (right to buy)
21.01
2021-07-10
4
A
0
25000
0.00
A
2031-07-09
Common Stock
25000
25000
D
This option was granted on July 10, 2021. The shares underlying the option are scheduled to vest over four years in equal quarterly installments from July 1, 2021.
Senior Vice President of Business Development
/s/ Richard Scalzo, Attorney-in-Fact
2021-07-13